Casandra
Casandra Test Code QD86645Version 1 (DRAFT)
Performing Lab
Lab Quest DiagnosticsLab Test ID 17717
CA 125 with HAMA Treatment
Clinical Use
Order TestUse
Measures levels of cancer antigen 125 (CA‑125)—a glycoprotein tumor marker often elevated in epithelial ovarian cancer and other conditions—while treating the specimen to remove interference from human anti‑mouse antibodies (HAMA), improving accuracy in patients who may produce such heterophilic antibodies.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Not provided.
Biomarkers
CA‑125, Hama Treated
AnalyteCA‑125, Hama Treated • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Related Tests
Other tests from different labs that may be relevant
Cancer Antigen (CA) 125 in the Presence of Human Antimouse Antibodies (HAMA)
Labcorp
Cancer Antigen (CA) 125
Labcorp
Human Anti-mouse Antibody (HAMA)
Mayo Clinic Lab
Cancer Antigen 125 (CA 125), Serum
Mayo Clinic Lab
Human Antimouse Antibodies
Labcorp
Cancer Antigen (CA) 125 (Serial Monitor)
Labcorp
Ovarian Cancer Monitor
Labcorp
Cancer Antigen (CA) 15-3
Labcorp
Cancer Antigen 15-3 (CA 15-3), Serum
Mayo Clinic Lab
Cancer Antigen (CA) 15-3 (Serial Monitor)
Labcorp